
-
Praxis Precision Medicines NASDAQ:PRAX Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying insights from genetic epilepsies to broader neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio, including multiple disclosed programs across CNS disorders including depression, epilepsy, movement disorders and pain syndromes, with three clinical-stage product candidates.
Location: | Website: praxismedicines.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
1.033B
Cash
357M
Avg Qtr Burn
-24.87M
Short % of Float
17.83%
Insider Ownership
0.50%
Institutional Own.
-
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Ulixacaltamide (PRAX-944) (T-type calcium channel blocker) Details Essential tremor Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 3 Data readout | |
PRAX-628 Details Epilepsy, Focal Onset Seizures | Phase 2/3 Data readout | |
PRAX-628 Details Epilepsy, Focal Onset Seizures | Phase 2b Data readout | |
PRAX-628 Details Epilepsy, Focal Onset Seizures | Phase 2b Update | |
Ulixacaltamide (PRAX-944) (T-type calcium channel blocker) Details Parkinson's disease | Phase 2 Data readout | |
PRAX-562 Details Developmental and Epileptic Encephalopathy | Phase 2 Data readout | |
PRAX-222 Details Developmental and Epileptic Encephalopathy | Phase 1/2 Data readout | |
PRAX-114 (GABAA receptor PAM) Details Perimenopausal Depression | Failed Discontinued | |
PRAX-114 (GABAA receptor PAM) Details Major depressive disorder | Failed Discontinued |